Last week, experts in healthcare communications gathered at Grosvenor House for the 2015 Communiqué awards, which saw Aurora as finalists in four categories including digital communications, patient/consumer programmes, media relations and writing excellence for Novartis and Novo Nordisk.
We were delighted to receive two Highly Commended awards for SymTrac, the first NHS approved app for people with multiple sclerosis (MS) developed for Novartis, in the categories of Excellence in Digital Communications – Consumer Health and Excellence in Patient/Consumer Health Programmes. SymTrac is a smartphone application that allows people with MS to effectively track their symptoms in order to report to their doctor. It also includes additional content to help people manage their condition, including exercises provided by the MS Trust. The judges called SymTrac a “master class in patient-centred programme design” noting that it was “such a brilliant piece of marketing; strong stakeholder engagement and a highly collaborative approach to its development. They made sure to touch every digital setting and getting SymTrac into the NHS app store was a massive endorsement of the work”.
Neil Crump, MD and owner of Aurora commented on the results, “The app is a great example that co-creation with patients to develop a tool can really help effectively manage and record details of their MS in a way that fits modern lifestyle. As an award judge I know how tough it is to secure a highly commended at Communiqué. This is a great team achievement.”
The Communiqué awards recognise achievements in healthcare communications across the pharmaceutical industry, public and third sectors. The award ceremony took place at Grosvenor House Hotel, London, on Thursday 2 July 2015.